Financials data is unavailable for this security.
View more
Year on year Biora Therapeutics Inc 's revenues fell -98.69% from 305.00k to 4.00k. This along with an increase in selling, general and administrative costs has contributed to a reduction in net income from a loss of 38.16m to a larger loss of 124.12m.
| Gross margin | -- |
|---|---|
| Net profit margin | -10,094.19% |
| Operating margin | -8,158.95% |
| Return on assets | -255.56% |
|---|---|
| Return on equity | -- |
| Return on investment | -- |
More ▼
Cash flow in USDView more
In 2023, cash reserves at Biora Therapeutics Inc fell by 15.28m. Cash Flow from Financing totalled 30.78m or 769,525.00% of revenues. In addition the company used 48.50m for operations while cash from investing totalled 2.44m.
| Cash flow per share | -24.06 |
|---|---|
| Price/Cash flow per share | -- |
| Book value per share | -24.85 |
|---|---|
| Tangible book value per share | -26.54 |
More ▼
Balance sheet in USDView more
| Current ratio | 0.20 |
|---|---|
| Quick ratio | -- |
| Total debt/total equity | -- |
|---|---|
| Total debt/total capital | -- |
More ▼
